# Takeshi Morimoto

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/takeshi-morimoto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,831 |
| Field | Coronary Interventions and Diagnostics |
| h-index | 75 |
| i10-index | 481 |
| Last Known Institution | Hyogo Medical University |
| OpenAlex ID | https://openalex.org/A5080185082 |
| ORCID iD | 0000-0002-6844-739X |
| Works | 1,208 |

## Researcher papers

Showing 12 of 13.

- [Predicting Successful Guidewire Crossing Through Chronic Total Occlusion of Native Coronary Lesions Within 30 Minutes](https://scholariq.org/papers/predicting-successful-guidewire-crossing-through-chronic-total-occlusion-of/)
- [Endovascular Therapy for Acute Stroke with a Large Ischemic Region](https://scholariq.org/papers/endovascular-therapy-for-acute-stroke-with-a-large-ischemic-region/)
- [Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI](https://scholariq.org/papers/effect-of-1-month-dual-antiplatelet-therapy-followed-by-clopidogrel-vs-12-month/)
- [Adverse drug events and medication errors: detection and classification methods](https://scholariq.org/papers/adverse-drug-events-and-medication-errors-detection-and-classification-methods/)
- [Adverse drug events and medication errors: detection and classification methods](https://scholariq.org/papers/adverse-drug-events-and-medication-errors-detection-and-classification-methods-2/)
- [Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study](https://scholariq.org/papers/early-immune-related-adverse-events-and-association-with-outcome-in-advanced-non/)
- [Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome](https://scholariq.org/papers/effect-of-intensive-statin-therapy-on-regression-of-coronary-atherosclerosis-in/)
- [Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation](https://scholariq.org/papers/antiplatelet-therapy-and-stent-thrombosis-after-sirolimus-eluting-stent/)
- [Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials](https://scholariq.org/papers/effects-of-aspirin-on-risks-of-vascular-events-and-cancer-according-to/)
- [Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis](https://scholariq.org/papers/initial-surgical-versus-conservative-strategies-in-patients-with-asymptomatic/)
- [Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome](https://scholariq.org/papers/comparison-of-clopidogrel-monotherapy-after-1-to-2-months-of-dual-antiplatelet/)
- [Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study](https://scholariq.org/papers/efficacy-and-safety-of-nivolumab-in-previously-treated-patients-with-non-small/)

## Researcher topics

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

## Researcher university

- [Hyogo Medical University](https://scholariq.org/institutions/hyogo-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.